InsidersTradesSigma
Track the Embecta Corp. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Embecta Corp. has published 106 reports. Market capitalisation: €286.1m. The latest transaction was reported on 8 September 2026 (Cession). Among the most active insiders: Kurdikar Devdatt. All data is free.
106
Insider Decl.
n/a
Thresholds
€1m
13 ops.
Buy Volume
€31,814
1 ops.
Sell Volume
56Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,760 of 29,063 companies
74.4
score / 100
Value94
Quality55
FCF yld64%
Earn yld33%
EV/EBITDA6.0x
ROE·
Gross mgn63%
Net mgn8.8%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 September 2026
Declarations106 total
6,293 shares@ US$5.875Common StockSEC:0000947871-26-000859:0
6,293 shares@ US$5.86220.013% mcap100.0% of flowCOMMONSEC144:0001000275-26-000105
20,000 shares@ US$4.6680.034% mcap30.4% of flowCommon StockSEC:0000947871-26-000788:0
Canonical exit: 10 Nov 2026 (T+90)
45,000 shares@ US$4.97440.081% mcap100.0% of flowCommon StockSEC:0000947871-26-000786:0
Canonical exit: 10 Nov 2026 (T+90)
20,000 shares@ US$4.990.036% mcap36.5% of flowCommon StockSEC:0000947871-26-000787:0
Canonical exit: 10 Nov 2026 (T+90)
30,000 shares@ US$4.69790.051% mcap9.7% of flowCommon StockSEC:0000947871-26-000789:0
Canonical exit: 10 Nov 2026 (T+90)
1,480 shares@ US$4.420.0023% mcap20.1% of flowCommon StockSEC:0000947871-26-000779:0
22,841 shares0Common StockSEC:0000947871-26-000165:0
22,841 shares0Common StockSEC:0000947871-26-000164:0
22,841 shares0Common StockSEC:0000947871-26-000163:0
22,841 shares0Common StockSEC:0000947871-26-000162:0
22,841 shares0Common StockSEC:0000947871-26-000161:0
22,841 shares0Common StockSEC:0000947871-26-000160:0
32,817 shares0Common StockSEC:0000947871-25-001053:0
38,783 shares0Common StockSEC:0000947871-25-001052:0
79,555 shares0Common StockSEC:0000947871-25-001051:0
288,386 shares0Common StockSEC:0000947871-25-001050:0
95,466 shares0Common StockSEC:0000947871-25-001049:0
37,789 shares0Common StockSEC:0000947871-25-001048:0
916 shares@ US$12.2842.7% of flowCommon StockSEC:0000947871-25-000735:0
10,000 shares@ US$10.599516.3% of flowCommon StockSEC:0000947871-25-000561:0
Canonical exit: 21 Aug 2025 (T+90)
4,948 shares@ US$12.0029.1% of flowCommon StockSEC:0000947871-25-000370:0
5,285 shares@ US$12.0038.2% of flowCommon StockSEC:0000947871-25-000368:0
3,249 shares@ US$12.0060.4% of flowCommon StockSEC:0000947871-25-000369:0
39,592 shares@ US$12.0038.0% of flowCommon StockSEC:0000947871-25-000367:0
25 of 106 declarations
关于 Embecta Corp.
Embecta Corp. 是一家专注于医疗保健和制药领域的公司，专门提供糖尿病管理解决方案。该公司在纳斯达克上市，股票代码为 EMBecta。